A long-lasting, complete hematologic and cytogenetic remission of chronic myelogenous leukemia after treatment with busulfan alone

被引：2
|
作者：
Mandigers, CMPW
Mensink, EJBM
van Kessel, AG
van der Plas, DC
Haanen, C
Hagemeÿer, A
de Witte, T
机构：
[1] Univ Nijmegen Hosp, Dept Hematol 544, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen Hosp, Dept Anthropogenet, NL-6500 HB Nijmegen, Netherlands
[3] Erasmus Univ, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands
来源：
ANNALS OF HEMATOLOGY | 1996年 / 72卷 / 06期
关键词：
busulfan; chronic myelogenous leukemia; cytogenetic; minimal residual disease; polymerase chain reaction;
D O I：
10.1007/s002770050188
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 44-year-old man suffering from cytogenetically and molecularly proven Philadelphia translocation-positive chronic myelogenous leukemia in chronic phase was treated with busulfan for 18 months and studied during a follow-up period of 13 years. Hematologically and cytogenetically, he attained a continuing complete remission, although at one point (9.5 years) at least, after attaining complete remission molecular analysis indicated the presence of minimal residual disease.
引用
收藏
页码：371 / 373
页数：3
相关论文
共 50 条
  • [31] LONG-LASTING REMISSION OF WEGENERS GRANULOMATOSIS AFTER COMBINED CHLORAMBUCIL AND PREDNISONE TREATMENT
    KUSTNER, W
    WEGENER, F
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1970, 95 (24) : 1315 - &
  • [32] PROLONGED CYTOGENETIC AND HEMATOLOGIC REMISSION OF BLASTIC TRANSFORMATION IN CHRONIC GRANULOCYTIC LEUKEMIA
    CANELLOS, GP
    BROWN, CH
    WHANGPEN.J
    SCHNIPPE.L
    CANCER, 1972, 30 (01) : 288 - &
  • [33] Complete cytogenietic remission with imatinib mesylate treatment in chronic myelogenous leukemia (CML) developed after renal transplantation
    Koca, E
    Cetiner, D
    Goker, H
    Aksu, S
    Ozcebe, OI
    Haznedaroglu, IC
    Turgan, C
    CLINICAL NEPHROLOGY, 2005, 64 (04) : 324 - 326
  • [34] Discontinuation of alpha-interferon treatment in patients with chronic myeloid leukemia in long-lasting complete molecular response
    Latagliata, Roberto
    Romano, Angela
    Mancini, Marco
    Breccia, Massimo
    Carmosino, Ida
    Vozella, Federico
    Montagna, Chiara
    Volpicelli, Paola
    De Angelis, Federico
    Petrucci, Luigi
    Serrao, Alessandra
    Molica, Matteo
    Salaroli, Adriano
    Diverio, Daniela
    Alimena, Giuliana
    LEUKEMIA & LYMPHOMA, 2016, 57 (01) : 99 - 102
  • [35] COMPLETE REMISSION OF BLASTIC PHASE OF CHRONIC MYELOGENOUS LEUKEMIA (BLCML)
    ARLIN, Z
    CHAGANTI, RSK
    GEE, T
    CLARKSON, B
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 196 - 196
  • [36] Eyelid localization in mantle cell lymphoma: long-lasting complete remission after surface brachytherapy
    Franco, Pierfrancesco
    Filippi, Andrea Riccardo
    Ricca, Irene
    Raucci, Carlo
    Ricardi, Umberto
    TUMORI JOURNAL, 2009, 95 (03): : 385 - 388
  • [37] Long-lasting complete Remission of metastatic malignant melanoma after reinduction with Ipilimumab, a case Report
    Mueller-Brenne, Tina
    Stanger, Christian
    Grabbe, Stephan
    Loquai, Carmen
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2012, 10 (09): : 683 - 683
  • [38] EXTRAMEDULLARY BLAST CRISIS IN A PATIENT WITH PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA IN COMPLETE CYTOGENETIC REMISSION
    OBRIEN, S
    WITT, R
    TALPAZ, M
    KANTARJIAN, H
    CANCER, 1991, 67 (07) : 1946 - 1949
  • [39] PROGRESSION AND PROGNOSIS OF CHRONIC MYELOGENOUS LEUKEMIA IN ACUTE STAGE - HEMATOLOGIC AND CYTOGENETIC ASPECTS
    MOTOMURA, S
    OGI, K
    KANEKO, S
    ACTA HAEMATOLOGICA, 1976, 56 (02) : 78 - 83
  • [40] Extramedullary blast crisis in a patient with chronic myelogenous leukemia in complete cytogenetic and molecular remission on interferon-α therapy
    Beedassy, A
    Topolsky, D
    Styler, M
    Crilley, P
    LEUKEMIA RESEARCH, 2000, 24 (08) : 733 - 735
12345